HE News Icon

HEOR News Roundup

Tuesday, Oct. 6, 2020 | Issue 522

email icon Twitter icon Facebook icon LinkedIn Icon Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

Syapse and FDA Leverage Real-World Data to Study Impact of COVID-19 on Cancer Patients

According to the National Cancer Institute, the COVID-19 pandemic has resulted in delays for cancer screening, diagnosis, and treatment, leading to an increase in cancer mortality across the board and a widening of existing health disparities.

Read More

[Webinar] The Informative Bayesian: Meta-analytic Predictive (MAP) Priors

Harnessing the Power of RWD in China

Can Economic Evaluation Achieve Meaningful Use in Reducing Healthcare Costs in the US?

[Podcast] Co-pay Cards, Co-pay Accumulators, and Co-pay Maximizers

HEOR news icon
Featured Events



“Are we clear?” Ensuring clarity in medical communications

October 7


Faster Science: HEOR, RWE & Market Access Sourcing

October 7


Syndicated Reports
HTA in Europe: Key Success Factors for Positive HTA Recommendations
Paying for Digital Health: Payer Insights
White Papers
Patient Centricity
How to Excel at Next Generation Trial Execution
  Real World Evidence Solutions (RWE-S) Scientist Analyst / Manager- Reimbursement Strategy Vice President/ Senior Vice President, Business Development Research Associate III/Senior Research Associate – Data Collection – Peri- and Post-Approval Studies  

Share this newsletter!